[Pathogenesis and neuroprotective therapy trial in chronic degenerative diseases. Status of antioxidants].
Gerlach
M
M
Klinische Neurochemie, Universitäts-Nervenklinik Würzburg.
Riederer
P
P
D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use; D002493:Central Nervous System Diseases / Q000503:physiopathology; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D009410:Nerve Degeneration; D009474:Neurons / Q000378:metabolism; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009498:Neurotoxins / Q000633:toxicity; D018384:Oxidative Stress; D010300:Parkinson Disease / Q000188:drug therapy / Q000503:physiopathology*
D000975:Antioxidants; D018696:Neuroprotective Agents; D009498:Neurotoxins; D004298:Dopamine